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Abstract
Machine learning (ML) is making a dramatic impact on cardiovascular magnetic resonance (CMR) in many ways.
This review seeks to highlight the major areas in CMR where ML, and deep learning in particular, can assist
clinicians and engineers in improving imaging efficiency, quality, image analysis and interpretation, as well as
patient evaluation. We discuss recent developments in the field of ML relevant to CMR in the areas of image
acquisition & reconstruction, image analysis, diagnostic evaluation and derivation of prognostic information. To
date, the main impact of ML in CMR has been to significantly reduce the time required for image segmentation
and analysis. Accurate and reproducible fully automated quantification of left and right ventricular mass and
volume is now available in commercial products. Active research areas include reduction of image acquisition and
reconstruction time, improving spatial and temporal resolution, and analysis of perfusion and myocardial mapping.
Although large cohort studies are providing valuable data sets for ML training, care must be taken in extending
applications to specific patient groups. Since ML algorithms can fail in unpredictable ways, it is important to
mitigate this by open source publication of computational processes and datasets. Furthermore, controlled trials are
needed to evaluate methods across multiple centers and patient groups.
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Introduction
Machine learning (ML) and artificial intelligence (AI)
are rapidly gaining importance in medicine [1, 2],
including in the field of medical imaging, and are likely
to fundamentally transform clinical practice in the com-
ing years [3, 4]. AI refers to the wider application of
machines that perform tasks that are characteristic of
human intelligence, e.g. infer conclusions from deduc-
tion or induction, while ML is a more restricted form of
computational processing which uses a mathematical
model together with training data to learn how to make
predictions. Rather than explicitly computing results
from a set of predefined rules, ML learns parameters
from examples and therefore has the potential to per-
form better at a task such as detecting and
differentiating patterns in data by being exposed to a
more examples. The most advanced ML techniques, also
called deep learning (DL), are especially well-suited for
this purpose (Fig. 1). Cardiovascular magnetic resonance
(CMR) is a field that lends itself to ML because it relies
on complex acquisition strategies, including multidimen-
sional contrast mechanisms, as well as the need for ac-
curate and reliable segmentation and quantification of
biomarkers based on acquired data, to help guide diag-
nosis and therapy management.
It is important for clinicians and researchers working
in CMR to understand the impact of ML on the field.
Thus, the purpose of this review is threefold: firstly, we
will provide a non-technical overview of the basics of
ML relevant to CMR. Secondly, we survey the various
ways ML has been applied to the field of CMR. Finally,
we provide an outlook on future directions and recom-
mendations for reporting results. Please also refer the
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glossary of terms for definitions of commonly used
terms in machine learning.
Machine learning basics
Consider the problem of reporting left ventricular (LV)
ejection fraction (LVEF) from a CMR study. A traditional
image processing method would typically define a se-
quence of steps a priori, e.g. selection of end diastolic (ED)
and end systolic (ES) frames, contouring of cavity and
myocardium using signal processing algorithms with a se-
quence of processing steps, calculation of cavity area per
slice, summation into volumes, and the calculation of
LVEF. In comparison, a ML method would learn from a
set of examples, e.g. hundreds of CMR studies with
ground truth segmentations, to optimize a mathematical
model which is then used to predict segmentations. In this
case the algorithm learns which parts of the data are im-
portant for the task, and how to put the information to-
gether to produce the result.
Standard machine learning models
In standard ML model, important characteristics or
features for performing a certain task are extracted from
images by using a designed feature set. In the example
above, features for myocardial contours may include
image contrast, noise characteristics, texture and motion.
Once the design process is complete, ML methods need
to be trained using example data. In this training phase,
parameters of the feature set model are learned. A
model is any function of the features used for prediction
and the parameters of the model dictate the actual pre-
dictions made. Once trained, the model can be used to
make a prediction for data not seen previously in the
training phase. ML models can perform either classifica-
tion where discrete labels such as the presence or ab-
sence of disease are determined, or regression, where
continuous variables such as T1 are estimated. Because
the models learn from examples, it is important that a
sufficiently large dataset with representative variability is
available for training. For evaluation of the model’s per-
formance it is of utmost importance to keep training
data that is used during model development and fine-
tuning separated from the test data that is used to evalu-
ate the model’s performance. Another dataset (usually
called the validation dataset), is used during the training
phase to help determine the optimal design of the ML
model. This dataset is used to optimize model parame-
ters, and to ensure that the model does not overfit.
Deep learning
One of the key steps in creating ML systems is designing
the optimal discriminative features for a given task. This
has proven highly challenging [5, 6]. A subfield of
machine learning that can address this challenge is DL.
Unlike standard ML methods, DL methods are able to
learn directly from the data, circumventing the need for
hand-crafting of discriminative features. In the example
of finding the contours of myocardium, DL methods
learn the image features most useful for predicting the
location of the contours.
Recent successes with DL have been fueled by four
synergistic advances: 1) the availability of large quantities
of high-quality digital image data for training; 2) the
ability of algorithms to learn relevant information
directly from images without the need for handcrafted
features; 3) low-cost powerful graphics processing unit
(GPU) hardware, and 4) open source development
libraries and working example networks made freely
available by companies and researchers. These advances
have led to the development of neural networks with
many layers, which is what ‘deep’ refers to in DL [7]. A
special type of DL network, the convolutional neural
network (CNN) is often used for image analysis tasks.
A typical CNN network is composed of multiple layers,
each with a well-defined architecture (Fig. 2). Convolution
layers refer to those which employ a set of filters that are
applied to the image to produce spatially dependent fea-
tures for the next layer. The intent is to learn the optimal
values of the filters (also called weights) so that features of
maximum relevance to the task are generated in the subse-
quent layers. Pooling layers (e.G. max pooling or average
pooling) downsample the spatial information so that
Fig. 1 Artificial intelligence (AI) can be seen as any technique that
enables computers to perform tasks characteristic of human
intelligence. Machine learning (ML) is generally seen as the
subdiscipline of AI which uses a statistical model together with
training data to learn how to make predictions. Deep learning (DL)
is a specific form of ML that uses artificial neural networks with
hidden layers to make predictions directly from datasets
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features become more canonical for the task. For classifica-
tion and some regression networks, a fully connected layer
is used in which each node is connected to all other nodes
in the layer. Segmentation networks often use upsampling
operations to return the image dimensions back to the in-
put image size. Skip layers are often employed, which en-
able the propagation of fine details from one layer to
another, with the intent of recovering fine imaging features
and improving gradient propagation during training. Fi-
nally, a softmax layer performs a non-linear function which
rescales the components to give a non-negative probability
to each pixel class. This ensures that outputs sum up to 1
in the output layer. Often deep CNN implementations con-
tain many millions of weights. Although the features result-
ing from the convolutions in the intermediate layers
contain information pertinent to the task, it is often difficult
to interpret how the network makes its predictions, or why
it failed. However, DL is currently the most popular ML
architecture for medical image analysis. A recent survey [8]
shows more than 300 DL papers have been contributed to
the medical image analysis field, including CMR, in the 6
years to 2017, with the numbers growing exponentially.
Supervised and unsupervised learning
Based on the availability of reference labels in the training
data, ML algorithms are commonly divided into supervised
and unsupervised learning. In supervised learning, training
data are accompanied with ground truth labels, e.g. cases
with pathological status, images with expert-drawn con-
tours, or cases with cardiac volume and function measure-
ments. Supervised learning is the most commonly used
approach in ML because learning from expert-annotated
labels is the most intuitive way to mimic human
performance. This is in contrast to unsupervised learning
where training data are given without labels. Unsupervised
learning is more challenging for building a prediction
model, because it is closer to natural learning by discover-
ing structures through observation [7]. Currently, a typical
use of unsupervised learning is to explore hidden structure
inside the training data. An example relevant to CMR is the
work by Oksuz et al. who used unsupervised dictionary-
based learning to segment myocardium from cine blood
oxygen level dependent (BOLD) CMR [9].
ML model parameters can be estimated by assuming a
simple functional relationship between the data and the la-
bels, for instance between CMR images and a certain diag-
nosis. A classic example is linear discriminant analysis,
which learns to fit a hyperplane to the training data by opti-
mizing linear coefficients, e.g. to separate patients with re-
duced LVEF from subjects with normal LVEF. However,
typical problems are complex and multi-dimensional with a
large amount of data, and simple mathematical relation-
ships cannot be assumed. Alternatively, ML model parame-
ters can be optimized by an iterative process designed to
refine the model behavior under some regularization con-
straints. Regularization is a mathematical tool to take into
account prior information when solving an optimization
task. Examples are support vector machines, e.g. applied to
characterize vessel disease from intravascular images [10],
random forests e.g. applied for T2 map quantification [11])
and DL CNNs, which is the focus of this review.
Current applications of machine learning in CMR
Image acquisition and reconstruction
Efficient, high-quality CMR demands careful attention to
proper patient positioning as well as planning of imaging
Fig. 2 Machine learning will impact all aspects of cardiovascular magnetic resonance imaging from patient scheduling to image analysis
and prognosis
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planes and volumes [12]. In current clinical practice,
CMR examinations are therefore performed by highly
experienced operators. Several of these acquisition-
related aspects of the CMR examination, which are
currently performed manually on most commercial
CMR systems, can be either automated or substantially
shortened using ML. Multiple CMR hardware vendors
are working on workflow optimizations such fully auto-
mated localization of the heart and planning of image
acquisition planes aligned with the principal cardiac axes
[13, 14]. Other investigators have applied ML to
automate optimal frequency adjustment for CMR at 3 T
[15], and to create a scan control framework that detects
image artifacts during the scan and self-corrects imaging
parameters or triggers a rescan if the prediction indi-
cates the current slice has artifacts [16].
While CMR imaging offers a range of advantages for as-
sessment of cardiac structure and function, acquisition of
CMR images is slow as it is complicated by cardiac and re-
spiratory motion. This imposes significant demands on
patients (e.g. in terms of length of scan time and length of
breath-holds) as well as making CMR expensive and less
accessible. Over the last decade approaches such as paral-
lel imaging and compressed sensing (CS) as well as real-
time imaging have been increasingly employed to acceler-
ate the acquisition of CMR images [17–26]. Techniques
such as CS are particularly attractive for accelerating
CMR as they undersample k-space, thereby leading to fas-
ter image acquisition. CS techniques such as [27–29] can
be regarded as ML methods that exploit spatiotemporal
redundancies in CMR data to learn how to recover an
uncorrupted image from undersampled k-space measure-
ments. For this, CS techniques exploit the sparsity (or
compressibility) of CMR images. More recently DL tech-
niques have emerged that use convolutional neural net-
works in order to replace the generic sparsity model used
in CS techniques with a model that is learnt from training
data [30, 31]. An advantage of these DL approaches is that
they not only offer superior performance in terms of re-
construction quality but that they also offer high effi-
ciency, e.g. very fast reconstruction speeds, making clinical
deployment feasible [31] (Fig. 3).
More recently, DL approaches that exploit spatiotem-
poral redundancy via recurrent CNNs have been pro-
posed which are more compact than cascades of CNNs
[32]. A remaining challenge is the integration of DL ap-
proaches with existing approaches for the acceleration of
CMR, such as parallel or real-time imaging. Accelerated
imaging is necessary in high-dimensional (e.g. 3D or 4D)
imaging for late gadolinium enhancement (LGE), flow or
perfusion imaging. DL techniques have the potential to
be applied to reduce the reconstruction time of highly
accelerated 3D or 4D dataset. Figure 4 shows an
example 3D LGE image reconstructed using DL with an
acceleration factor of 5.
Image segmentation
Delineating the borders of the chambers and myocar-
dium (a process known as segmentation) is mandatory
in CMR post processing [33], but it is a time-consuming
task. Experienced readers may produce high precision
manual contours, but differences among expert readers
Fig. 3 Deep learning network for reconstruction of undersampled CMR images
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are still known to occur [34]. A large body of research
has been dedicated to developing automated CMR seg-
mentation methods (see reviews in [35, 36]), but manual
corrections are still needed in the areas where there are
lots of trabeculae, the LV outflow tract, apical slices,
as well the right ventricle. ML algorithms can be
very helpful to further automate this task to increase
the productivity of CMR segmentation while improv-
ing accuracy and reproducibility [37] over the tech-
niques described in the two reviews mentioned
earlier [35, 36]. In general, DL-based fully automated
LV segmentations are highly accurate with 9 out of
10 recently developed methods [37] achieving Dice
similarity coefficients of 0.95 or better.
DL frameworks developed for general image segmen-
tation can be applied directly to segment the myocar-
dium and cardiac chambers from CMR images, often by
using pixel-based classification. Many reports have been
based on the U-Net architecture [38]. For instance, a
basic CNN layout with 9 convolutional layers and a sin-
gle upsampling layer was used to segment short-axis
CMR images [39]. A fully convolutional approach with a
simpler upsampling path has been suggested by Bai et al.
[40] and successfully applied for pixelwise segmentation
of 4-chamber, 2 chamber and short axis CMR images in
less than 1 min. Contextual 3D spatial information can
also be integrated in the CNN architecture by providing
features learnt from adjacent slices [41] or detecting a
canonical view before segmentation [42]. Several studies
have combined CNN with other ML algorithms, such as
constraining the optimization process by constraining
the network with information about the shape of the
heart [43] or using the output of the DL model as the
initial template for a deformable model segmentation
[44, 45].
A different approach in DL segmentation is to perform
regression rather than pixel classification. In [46], a net-
work was trained to automatically identify myocardium
and detect the center of the cavity. Then another net-
work was trained to estimate radii from the cavity cen-
ter, producing smooth epicardial and endocardial
contours. A similar approach was also proposed by [47],
where a boundary regression was performed on both left
and right ventricles on short-axis images producing con-
tours instead of pixel classification. Examples of image
segmentation based on DL are shown in Figs. 5 and 6.
DL methods can also calculate functional parameters
from imaging, e.g. fully automated determination of
LVEF, which subsequently can be used as a basis to tri-
age patients into different disease categories using hand-
crafted features [35, 48]. Puyol-Antón et al. [49] have
taken this approach a step further and used a database
of CMR and cardiac ultrasonography images as well as
clinical information to design a ML-based diagnostic al-
gorithm that can fully automatically identify patients
with dilated cardiomyopathy using a support vector
machine.
Myocardial tissue characterization
ML has been applied to a variety of myocardial tissue
characterization tasks. For example, scar volume from
LGE CMR is a quantitative imaging biomarker with in-
herent prognostic information, where application of ML
allows to overcome the need for subjective, time-
consuming and labor-intensive manual delineation cur-
rently used in routine clinical practice. Even when using
the current thresholding techniques for LGE quantifica-
tion, accuracy and reproducibility remain a major chal-
lenge due to variations among different CMR centers
[50], variations in gadolinium kinetics, and the patchy,
Fig. 4 Late gadolinium enhancement (LGE; red arrows) images with isotropic spatial resolution of 1.4 mm3 reconstructed using deep learning
from a prospectively five-fold randomly undersampled 3D LGE dataset in a patient with hypertrophic cardiomyopathy
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Fig. 5 Some examples of deep learning based myocardial segmentation on long-axis CMR images, trained from almost 5000 cases. A U-Net
network architecture was used in this case to classify myocardium (red) and cavity (blue)
Fig. 6 Scar and myocardium segmentation results for slices from four different patients. Contours resulting from manual (top row) and automatic
(lower row) segmentations for the epicardium (blue), endocardium (red), and scar (yellow) boundaries are overlaid on late gadolinium
enhancement (LGE) images
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multifocal appearance of LGE, e.g. in patients with
hypertrophic cardiomyopathy (HCM). To address these
shortcomings, a novel, ML-based approach to LGE
quantification has recently been suggested by Fahmy
et al. [51].
Cardiac relaxometry has demonstrated capabilities for
further quantitative tissue characterization. For example,
T1 mapping has proven beneficial for the identification
of diffuse myocardial fibrosis as well as myocardial
edema and lipid deposition. While there have been nu-
merous reports on data acquisition, little attention has
been paid to data analysis and reporting. Recent work
has shown that ML can also be applied to streamline
data processing and analysis for myocardial tissue
characterization [51–55] (Table 1 and Fig. 7).
The ability of ML techniques to cope with high-
dimensional data has recently facilitated the exponential
growth of a novel field called radiomics. The term radio-
mics reflects a process of converting digital medical
images into mineable high-dimensional data [56] by
extracting a high number of handcrafted quantitative
imaging features based on a wide range of mathematical
and statistical methods. Various features can be
extracted from images, the most important being mor-
phologic, intensity-based, fractal-based, and texture fea-
tures (subsumed under the term “texture analysis” [TA])
[57]. Texture features model spatial distributions of pixel
grey levels and allow for the segmentation, analysis and
classification of medical images according to the under-
lying tissue textures [58], thus offering the potential to
overcome limitations of a pure visual image interpret-
ation [59] (Fig.8).
Although radiomics and TA have been applied most
prominently in the fields of oncologic and neurologic
imaging, the first applications have been described for
CMR. Since myocardial tissue characterization remains
an important but complex and challenging task for dif-
ferentiating amongst various cardiac diseases, the appli-
cation of radiomics to CMR imaging data appears to be
appealing in order to deliver further insights into the
complex tissue changes and pathology of cardiovascular
diseases.
The first applications of radiomics and TA in CMR
have been reported for segmentation of scarred tissue
areas in myocardial infarction [60–62], allowing for
enhanced visualization of scarred myocardium and
extracting information about the characteristics of the
underlying myocardial tissue (Table2). Since then,
several studies have been published, showing the
feasibility of TA to differentiate between acute and
chronic infarction [63], based either on a combination
of non-contrast cine and LGE imaging [64], or based
on cine imaging alone [59, 65, 73].
Besides infarction, other applications of TA and radio-
mics have recently been reported for CMR. Several
smaller studies demonstrated the use of texture features
for differentiating amongst several causes of myocardial
hypertrophy (i.e. HCM, amyloid and aortic stenosis) and
healthy controls [74], or to detect fibrosis in HCM pa-
tients [66, 67]. Cheng et al. [68] evaluated the prognostic
value of texture features based on LGE imaging in HCM
patients with systolic dysfunction, demonstrating that in-
creased LGE heterogeneity was associated with adverse
events in HCM patients with systolic dysfunction. Re-
cently, TA has been applied to native T1mapping for
discriminating between hypertensive heart disease and
HCM patients, providing incremental value over global
native T1 mapping [69].
Myocardial inflammation is another interesting topic,
where radiomics and TA are extremely appealing in
order to overcome the current limitations of qualitative
as well as novel quantitative CMR sequences [11, 75].
Recent work has shown that averaging T1 and T2 values
derived from T1 and T2 mapping over the entire
myocardium has low sensitivity and specificity for de-
tecting myocardial inflammation [11, 72, 75], and that
analysis of inflammation-induced tissue inhomogeneity
on T1 and/or T2 maps might enable more accurate
quantification of myocardial inflammation [11, 71, 76].
Very recently, a first application of radiomics on T1 and
Table 1 Machine learning and deep learning for LGE quantification and parametric mapping
Author Myocardial disease Image substrate Application
Fahmy et al., 2018
(Ref. 51)
HCM LGE Delineate and quantify scar volume in patients with HCM
Hann et al., 2018
(Ref 52)
T1 mapping Automated LV segmentation of T1 maps using a ShMOLLI sequence in order to
speed up LGE quantification based on T1 mapping
Fahmy et al., 2019
(Ref 53)
Various diseases T1 mapping DL based image analysis and motion correction for myocardial T1 mapping to
provide fast and automated T1 mapping analysis (DICE: 0.85)
Farrag et al., 2019
(Ref 55)
Myocardial infarction T1 mapping and CINE DL based automated LV segmentation of T1 maps using a ShMOLLI sequence
(DICE: 0.84)
Martini et al., 2018
(Ref 54)
Various diseases T1 mapping Automated segmental analysis of T1 maps (DICE: 0.98, Jaccard: 0.97)
ML machine learning, DL deep learning, HCM hypertrophic cardiomyopathy, LGE late gadolinium enhancement, shMOLLI shortened modified Look-Locker
inversion recovery
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T2 mapping in a cohort of patients with biopsy-proven
acute infarct-like myocarditis has demonstrated an
excellent diagnostic accuracy of TA [70] and the con-
cept has also been shown to be applicable to the
much more challenging diagnosis of chronic myocar-
dial inflammation or myocarditis presenting with
heart-failure symptoms [77].
Prognosis
Information in CMR images obtained for diagnostic pur-
poses can also be used for prognosis. In a meta-analysis
of 56 studies containing data of 25,497 patients with
suspected or known coronary artery disease (CAD) or
recent myocardial infarction, El Aidi et al. [78] found
that LVEF was an independent predictor of future car-
diovascular events; predictors for patients with suspected
or known coronary artery disease (CAD) were wall mo-
tion abnormalities, inducible perfusion defects, LVEF,
and presence of infarction. Although meta-analyses such
as these can help identify imaging features important for
prognosis, selection of potentially relevant features is a
manual process based on presumed pathophysiological
importance and the ability to easily and reproducibly
quantify parameters of interest. Another important limi-
tation is that ‘traditional’ meta-analysis often fails to cap-
ture the heterogeneity between studies and patients in
sufficient detail to establish the association between
CMR findings and outcome. Furthermore, in almost all
Fig. 7 Myocardial T1 mapping at five short axial slices (apex to base from left to right respectively) of the left ventricle of one patient. a
Automatically reconstructed map (after automatic removal of myocardial boundary pixels) overlaid on a T1 weighted image with shortest
inversion time; (a) Manually reconstructed T1 map. The contours in (b) represent the myocardium region of interest manually selected by the
reader. In Fig. c scatter plots are shown of the automatic versus manual myocardium T1 values averaged over the patient volume (left) and each
imaging slice (right). Solid lines represent the unity slope line
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studies just a small fraction of all available information
about individual patients is taken into account. Machine
learning, on the other hand, is ideally suited in finding
intrinsic structure within patient phenotypic data con-
taining a high number (i.e. hundreds or even thousands)
of variables, which can then be evaluated both retro-
spectively and prospectively for predicting outcomes.
Thus, ML is much better suited for dealing with the
high-dimensionality of ‘real-world’ datasets and can be
used for unbiased identification of prognostically im-
portant variables. ML is also ideally suited to incorporate
information from electronic health records (EHR), la-
boratory data and genetic analyses.
Machine learning for prediction of adverse cardiovascu-
lar events has the potential to augment of traditional risk
scores, developed from the Framingham Heart Study and
other large cohort studies, with novel biomarkers derived
from imaging methods. In the Multi-Ethnic Study of Ath-
erosclerosis (MESA), 6814 initially asymptomatic
participants were followed for over 12 years. Over 700 var-
iables were collected. Ambale-Venkatesh et al. [79] used a
random survival forests technique to identify the top-20
predictors of each outcome measure. In addition to ca-
rotid ultrasound as a predictor for stroke, and coronary
calcium score as a predictor of atherosclerotic cardiovas-
cular disease, CMR derived LV structure and function
were among the top predictors for incident heart failure
[79]. The random survival forest risk prediction performed
better than established risk scores with increased predic-
tion accuracy. Another application is in dimension reduc-
tion methods, which show promise in the detection of
multidimensional shape features to characterize ventricu-
lar remodeling. Mass, volume and univariate measures
such as sphericity have shown prognostic value in MESA
[80]. Zhang et al. [81] applied information maximizing
component analysis to determine shape features which
best characterize differences between patients with myo-
cardial infarction and asymptomatic volunteers.
Fig. 8 Radiomics in CMR. Radiomic feature extraction can be performed on all types of CMR images, e.g. cine images or T1 / T2 maps. The
myocardium is segmented either manually or automatically using DL algorithms and feature extraction is performed. Whereas shape features are
of high interest in oncologic imaging, radiomics in CMR mostly rely on intensity based / histogram, texture features and filter methods such as
wavelet transform. After extracting a high number of quantitative features from CMR images, high-level statistical modelling involving ML and DL
methods is applied in order to perform classification tasks or make predictions in a given dataset
Leiner et al. Journal of Cardiovascular Magnetic Resonance           (2019) 21:61 Page 9 of 14
ML has also been used to predict outcome in patients
with cardiovascular disease. In a small proof-of-concept
study, Kotu et al. [82] used supervised ML to predict the
occurrence of cardiac arrhythmia in patients who sur-
vived infarction. The investigators found that CMR-
derived scar texture features based on scar gradient and
local binary patterns along with information about size
and location of the scar demonstrated discriminative
power for risk stratification comparable to currently
used criteria such as LVEF and scar size. Finally, Bello
et al. [83] used CMR-derived features together with clin-
ical information to train a DL classifier that can predict
outcome in patients with pulmonary hypertension. A
dense motion model was used to identify patterns of
right ventricular (RV) motion associated with adverse
outcomes, with superior results to prognostication based
on RV ejection fraction or strain.
ML methods have also been used to quantify relation-
ships between cardiac morphology and genetic variations.
For example, Schafer et al. found associations between
titin-truncating variants and concentric remodeling in
healthy individuals [84]. Mass univariate models were
used to find associations with single nucleotide polymor-
phisms (SNPs) in genome-wide association studies
(GWAS) studies [85]. Work by Peressutti et al. [86] has
shown that ML could be used to identify patients with a
favorable response to cardiac resynchronization therapy
(CRT) by supervised learning of relationships between
cardiac motion abnormalities, EKG data, clinical informa-
tion and the success of CRT as assessed at 6-months
follow-up. The same group of investigators has also dem-
onstrated that more detailed analysis of myocardial strain
at multiple different anatomical scales can be used to re-
fine prediction of CRT response [87].
Barriers to implementation
Although ML and DL are powerful new methods which
can help optimize the entire CMR imaging value chain,
there are also several limitations that need to be men-
tioned. The most important present limitations include
difficulty with rare entities and rare presentations of
common entities such as congenital heart disease. Other
difficulties include reliance on small, fixed inputs with
long-range or heterogenous dependencies such as
Table 2 Radiomics and texture analysis in CMR
Author Myocardial disease Image substrate Application
Beliveau, P. et al., 2015
(Ref 63)
Myocardial fibrosis
(rat model)
LGE Detection of age-related myocardial fibrosis (correlation to
histopathology)
Engan, K. et al., 2010
(Ref 60)
Myocardial infarction LGE Discrimination of patients with low risk of arrhythmias from
those with high risk of arrhythmias
Kotu, L.P. et al., 2013
(Ref 61)
Myocardial infarction LGE Automated segmentation of scarred tissue areas
Kotu, L.P. et al., 2013
(Ref 62)
Myocardial infarction LGE Enhanced visualization and segmentation of scarred myocardium
Larroza, A. et al., 2017
(Ref 64)
Myocardial infarction LGE, Cine Differentiation between acute and chronic MI (AUC 0.86 for LGE,
0.82 for Cine)
Baeßler, B. et al., 2018
(Ref 53)
Myocardial infarction Cine Differentiation between normal myocardium and small (AUC 0.92)
as well as large scar (AUC 0.93)
Larroza, A. et al., 2018
(Ref 65)
Myocardial infarction Cine Differentiation between nonviable, viable, and remote myocardial
segments; extraction of TA features over the entire cardiac cycle;
AUC 0.85
Schofield, R. et al.,
2016 (Ref 66)
Hypertrophic heart (hypertrophic
cardiomyopathy, amyloid, aortic
stenosis)
Cine Differentiation amongst several causes of myocardial hypertrophy
(HCM, amyloid and aortic stenosis) and healthy controls
Thornhill, R.E. et al.,
2014 (Ref 67)
Hypertrophic cardiomyopathy LGE Differentiation between segments with and without hypertrophy
and fibrosis
Baeßler, B. et al., 2018
(Ref 68)
Hypertrophic cardiomyopathy Native T1-weighted Differentiation between HCM patients and controls (AUC 0.95)
Cheng, S. et al., 2018
(Ref 69)
Hypertrophic cardiomyopathy LGE Association of adverse events in HCM patients with systolic
dysfunction with increased LGE heterogeneity
Neisius, U. et al., 2018
(Ref 70)
Hypertensive heart disease,
hypertrophic cardiomyopathy
Native T1 map Discrimination between hypertensive heart disease and HCM
patients with incremental value over global native T1 mapping
Baeßler, B. et al., 2018
(Ref 71)
Acute myocarditis Native T1 mapping,
T2 mapping
Diagnosis of biopsy-proven acute infarctlike myocarditis
(AUC 0.88)
Baeßler, B. et al., 2017
(Ref 72)
Dilated cardiomyopathy-like
myocarditis
Native T1 mapping,
T2 mapping
Diagnosis of biopsy-proven acute myocarditis presenting with
symptoms of heart failure
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medical charts, prior exams, and dealing with multiple
CMR imaging sequences and acquisition planes. An-
other limitation is the ‘black-box’ nature of DL algo-
rithms since it is often unclear what information is used
to come to a certain classification or result. Techniques
to visualize salient features can potentially help address
this limitation [88]. Furthermore, the present lack of
model robustness and lack of portability with respect to
different CMR scanners, sequences, imaging parameters
and institutions need to be addressed. Another barrier in
this regard is the lack of large, publicly available CMR
datasets that can be used to objectively compare differ-
ent (commercially available) algorithms with regard to
their performance. Finally, many current ML and DL
techniques are susceptible to adversarial attacks that
may lead to erroneous results [89].
Conclusions and future outlook
ML, and DL in particular, is beginning to be applied to
different types of cardiac imaging [90]. Besides image
interpretation, there are many tasks in the imaging
process that can potentially benefit from application of
ML. In the short term, ML techniques are highly likely
to be incorporated in the image acquisition and recon-
struction domains, in the postprocessing workflow and
analysis of advanced image features beyond visually
identifiable features as well as multi-dimensional
contrasts and their interpretation. One promising
method is to use DL methods to simulate images, both
to augment the size and the variability in the training
datasets for segmentation and classification networks
and to characterize bias between different imaging
modalities. A CMR scar simulation method has re-
cently shown to improve identification of scar in LGE
images [91]. Another promising technique is
reinforcement learning, in which an agent is trained
by trial and error using feedback from previous ac-
tions and experiences [92]
Despite the significant advances as described above
there are currently no published clinical trials in which
ML has been compared with human evaluation of CMR
datasets. Prospective controlled clinical trials are re-
quired to establish the effectiveness of algorithms in
clinical practice. The recently commenced CarDiac Mag-
nEtic Resonance for Primary Prevention Implantable
CardioVerter DebrillAtor ThErapy (DERIVATE) inter-
national observational registry is a good example of such
a study [93]. Furthermore, validation must be performed
not only using data from the same cohort as was
employed in the training, but also from other cohorts. In
particular, algorithms must be validated with data from
different centers and different acquisition devices. An ef-
ficient way of subsequently comparing the performance
of different algorithms is through so-called challenges –
competitions where research teams evaluate their algo-
rithms on a common dataset labeled with ground truth
information, e.g. Kaggle platform [94] and grand chal-
lenge platform [95]. Ground truth also must be meticu-
lously reviewed, in particular clinical reports since
clinicians may disagree in reporting style (and findings)
from center to center. Reported metrics are application
dependent but need to include not only sensitivity and
specificity but also positive predictive value and model
metrics such as the area under the receiver operating
characteristic curve. For the field to advance, algorithms
should be published using open source repositories to
enable replication, benchmarking, and improvement by
other groups.
Supplementary information
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